CoChat

Collateral damage and CRISPR genome editing

Open access
Thomas, Mark, Burgio, Gaetan, Adams, David J., Iyer, Vivek · 2019 · PLOS Genetics
Cited by 38

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

The simplicity and the versatility of clustered regularly interspaced short palindromic repeats/CRISPR-associated protein (CRISPR-Cas) systems have enabled the genetic modification of virtually every organism and offer immense therapeutic potential for the treatment of human disease.Although these systems may function efficiently within eukaryotic cells, there remain concerns about the accuracy of Cas endonuclease effectors and their use for precise gene editing.Recently, two independent reports investigating the editing accuracy of the CRISPR-Cas9 system were published by separate groups at the Wellcome Sanger Institute; our study-Iyer and colleagues [1]-defined the landscape of off-target mutations, whereas the other by Kosicki and colleagues [2] detailed the existence of on-target, potentially deleterious deletions.Although both studies found evidence of large on-target CRISPR-induced deletions, they reached seemingly very different conclusions. So, what do scientists using CRISPR gene-editing technology need to know? Off targets-the need for controlsIyer and colleagues used whole-genome sequencing (WGS) to identify potential off-target damage in mouse embryos and assessed the impact of genomic variation on de novo mutation calls.This study was undertaken in response to Schaefer and colleagues [3]-subsequently retracted-which reported a greater number of mutations at unexpected off-target locations in mice following the delivery of CRISPR reagents in mouse zygotes.Iyer and colleagues emphasised proper experimental controls and use of best practice in the choice of a single-guide RNA (sgRNA) and Cas9-mediated mutagenesis conditions.We demonstrated that if Cas9-mediated mutagenesis were causing off-target mutations, then the rate of these mutations was not distinguishable from the background de novo mutation rate in mouse embryos.The study concluded that efficient CRISPR gene editing was possible without a significant increase in de novo mutation rates, supporting the development of CRISPR-Cas9 as a therapeutic tool.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1007994

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 38

Metadata

Authors
Thomas, M., Burgio, G., Adams, D. J., & Iyer, V.
Venue
PLOS Genetics
Published
2019-03-14
Volume
15
Issue
3
Pages
e1007994
ISSN
  • 1553-7390 (ISSN-L)
  • 1553-7404
OpenAlex
W2922243354
Cited by
38
References
10
FWCI
1.86
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Collateral damage and CRISPR genome editing. https://app.cochat.ai/papers/10.1371/journal.pgen.1007994
The paper
Thomas, M., Burgio, G., Adams, D. J., & Iyer, V. (2019). Collateral damage and CRISPR genome editing. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1007994

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.